Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Yao Xue Xue Bao ; 49(12): 1665-73, 2014 Dec.
Artículo en Zh | MEDLINE | ID: mdl-25920195

RESUMEN

In order to enhance the specificity of TNF-α monoclonal antibody to inflamed site, a bispecific antibody BsDb that targets TNF-α and the extra-domain B (ED-B) of fibronectin (FN) was constructed by covalently linking the anti-TNF-α single chain Fv antibody (TNF-scFv) and the anti-ED-B scFv L19 via a flexible peptide linker deriving from human serum albumin (HSA). ED-B is an antigen specifically expressed at the inflamed site. BsDb is expressed in E. coli, identified by immunoblot, and purified with affinity chromatography. This was followed by further examination of its bioactivities and pharmacokinetics. We demonstrated that BsDb retained the immunoreactivity of its original antibodies as it could simultaneously bind to TNF-α and ED-B and neutralize the biological action of TNF-α. In the collagen-induced arthritis mice model, BsDb selectively accumulate in the inflamed joint with a maximal uptake of (12.2 ± 1.50)% ID/g in a single inflamed paw and retain in the inflamed paw for at least 72 h. In contrast, BsDb showed a short serum half-life of (0.50 ± 0.05) h and a rapid clearance from normal tissues. The findings reported herein indicate that BsDb has good specificity to the inflamed site and low toxicity to normal tissues. BsDb is therefore likely to have greater clinical applications in the treatment of rheumatoid arthritis and other autoimmune diseases. This laid a stable basis for its preclinical study.


Asunto(s)
Anticuerpos Biespecíficos/química , Fibronectinas/química , Factor de Necrosis Tumoral alfa/química , Animales , Anticuerpos Monoclonales/química , Artritis Experimental , Escherichia coli , Semivida , Humanos , Ratones , Anticuerpos de Cadena Única/química
2.
Yao Xue Xue Bao ; 47(9): 1210-8, 2012 Sep.
Artículo en Zh | MEDLINE | ID: mdl-23227553

RESUMEN

In order to increase the plasma half-life and tissue specificity of IL-1 receptor antagonist, a recombinant fusion protein IL-1Ra-HSA, linked by a rigid peptide linker PAPAP, was engineered and expressed by the Pichia pastoris host cells. The fusion protein was secreted to the host cells culture, identified by Western blot, and purified by affinity chromatography. This was followed by a further examination of its bioactivity and pharmacokinetics. Our results demonstrated that the fusion protein retained the antagonist activity of IL-1Ra, capable of binding specifically to the IL-1 receptor on human melanoma A375.S2 cells, and inhibits the cytolytic effect of IL-1beta to A375.S2 cells. Albumin fusion dramatically extended the half-life of IL-1Ra and resulted in a specific accumulation of IL-1Ra in the arthritic paws and a lower distribution of IL-1Ra in other organs such as liver, kidney, spleen and lung in mice with collagen-induced arthritis. The findings reported herein indicate that the fusion protein is likely to have greater clinical applications in areas such as the treatment of rheumatoid arthritis.


Asunto(s)
Apoptosis/efectos de los fármacos , Artritis Experimental/metabolismo , Proteína Antagonista del Receptor de Interleucina 1 , Albúmina Sérica , Animales , Línea Celular Tumoral , Miembro Anterior/metabolismo , Semivida , Humanos , Proteína Antagonista del Receptor de Interleucina 1/genética , Proteína Antagonista del Receptor de Interleucina 1/metabolismo , Proteína Antagonista del Receptor de Interleucina 1/farmacocinética , Proteína Antagonista del Receptor de Interleucina 1/farmacología , Interleucina-1beta/toxicidad , Masculino , Melanoma/patología , Ratones , Ratones Endogámicos DBA , Pichia/genética , Pichia/metabolismo , Plásmidos , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes de Fusión/farmacocinética , Proteínas Recombinantes de Fusión/farmacología , Albúmina Sérica/genética , Albúmina Sérica/metabolismo , Albúmina Sérica/farmacocinética , Albúmina Sérica/farmacología , Distribución Tisular
3.
Zhong Yao Cai ; 34(5): 738-46, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21954562

RESUMEN

OBJECTIVE: To set up a suitable IEC-6 migration model for pharmacological research and observe the effect of complex polysaccharide from Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao to IEC-6 cell migration. METHODS: The main conditions related to the establishment of the model, including the planting density of the cell, the observation time after scratching, the concentration of the auxiliary material Matrigel, the treatment of the serum-starvation, the concentration of alpha-difluoromethylornithine (DFMO), an inhibitor of the cell migration, were investigated respectively; and the effects of the tested medicines on the model were observed. RESULTS: 4 x 10(5) cell/mL was the suitable planting density of the cell in the 6-well plate; at the 24th hour after scratching was the appropriate time to count the migrating cells; and the proper concentration of Matrigel was 5%; the serum-starvation could evidently reduce the migrating cells, so the culture medium should contain the serum; 2.5 - 5 mmol/L DFMO was proper for inhibition of the cell migration. Complex polysaccharide from Astragalus membranaceus and spermidine both can promote cell migration. CONCLUSION: The established model of IEC-6 cell migration was suitable for intestinal epithelial restitution such as the researches on pathophysiological mechanisms is the effects of the medicines on the cell migration.


Asunto(s)
Movimiento Celular , Células Epiteliales/efectos de los fármacos , Intestinos/citología , Modelos Biológicos , Polisacáridos/farmacología , Animales , Astragalus propinquus/química , Técnicas de Cultivo de Célula/métodos , Línea Celular , Ensayos de Migración Celular/métodos , Medios de Cultivo/metabolismo , Eflornitina/metabolismo , Células Epiteliales/citología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Intestinos/fisiología , Ratas , Espermidina/farmacología , Cicatrización de Heridas
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda